Skip to content
Wednesday 5 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
City PM

European business, markets and politics

FTSE 100
10,879.38
+0.20%
DAX
26,202.35
0.00%
CAC 40
8,666.63
0.00%
STOXX 50
6,486.70
0.00%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Tuesday 17 November 2009 7:00 pm

ALLEN DIAGNOSED WITH CANCER

By: admindrupal

Add as a preferred source on Google

Microsoft co-founder Paul Allen has been diagnosed with cancer. He has non-Hodgkin’s lymphoma and has begun chemotherapy. Allen left Microsoft in 1983 after being first diagnosed with Hodgkin’s disease, and is said to be optimistic he can survive this time also. He continues to work at his investment firm, Vulcan.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • NULL

Trending Articles

  • Ask the expert: How do I avoid double tax on my pension?

  • The Debate: should we release female prisoners to make space for men?

  • The only answers to over-tourism are prices or queues

  • Gary Stevenson is right the rich people want to help Britain – here’s how to let them do it

  • David Brent was supposed to be a satire, now he looks like a model for political leaders

More from City PM

  • Forvis Mazars and top partner hit with £600,000 fine for audit failings

    Accountancy
    Canada skyline representing the potential legal impact of Labours flexible working reforms on businesses
  • Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform

    Business Wire
  • Robotaxi rules row drives Waymo-Uber rift ahead of London launch

    Transport & Infrastructure
    Getty Images logo on a building facade, symbolizing brand presence in the media and photography industry.
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
  • Microsoft ‘back on track’, whilst Meta spending leaves investors ‘nervous’

    Tech
    Meta's Zuckerberg is leading the AI recruitment boom
  • Who’s buying your business? Don’t wait until you’ve built it to decide – here’s why

    Partner
    Panelists Alison Stuckless, Howard Davies, Will Fraser-Allan, and Karim Palant at SCALE EXPO SUMMIT Day 2
  • Multiplier Raises $35 Million Series B to Build a New Model for Professional Services

    Business Wire
  • Vena to Acquire Morpheo AI, Advancing Vena AI Through Vena Omega™, the Industry’s Only Cumulative Context Engine Built for Finance

    Business Wire
CityPM

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About City PM
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 City PM Ltd · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook